TGA Approval

APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial (241713)

ARTG ID

241713

ARTG Name

APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

May 17, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Ingredient Name

bivalirudin

Empowering clinical research with data-driven insights and AI-powered tools.

APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial (241713) - TGA 批准文号 | MedPath